Company History

In the last decade the bio-pharm industry has spent more than $1 trillion bringing 72 new cancer drugs to market. Patients and the healthcare systems around the world have spent many trillions paying for the drugs. According to a 2016 study …

Investor information

Shocking as it seems, overall cancer survival has barely changed over the past decade. Despite the advancement of target and other therapies, the 70 cancer drugs approved in that time gave patients only an average 2.1 more months of life than older drugs, according to a study in J.A.M.A.

USA, PCT, & China composition and use patents through 2038

Companies and Institutions Behind Our Success

Our Partners

ANU Pharmaceutical Company (Seattle, USA)

ANU Pharmaceutical Company is an incubator company for the early-stage development of novel oncology compounds.

PUMC Pharmaceuticals, Beijing, China

PUMC Pharmaceutical is a specialty pharmaceutical company.Since 1995, we have been working closely with the Peking Union Medical College (PUMC), the Chinese Ministry of Health and our international partners to meet the unmet medical needs of patients in China and around the world.

Prevail InfoWorks

Prevail InfoWorks is a system integration and analytics software company with a unique combination of clinical expertise and engineering prowess. Providing best in Class Modular Technology for Improved Timelines and early observations in clinical trials. Prevail is managing Neovia’s first-in-human trial for NEV-801

University of Iowa Pharmaceuticals

The University of Iowa Pharmaceuticals has been manufacturing and testing pharmaceutical products in compliance with cGMPs for over 40 years. UIP provides contract pharmaceutical formulation development, clinical supply, and commercial manufacturing and analytical testing services for Neovia